Literature DB >> 7554086

The role of mRNA stability and transcription in O6-methylguanine DNA methyltransferase (MGMT) expression in Mer+ human tumor cells.

R A Kroes1, L C Erickson.   

Abstract

We have recently reported that following depletion of O6-methylguanine DNA methyltransferase (MGMT) activity by acute streptozotocin (STZ) treatment to sensitize innately chloroethylnitrosourea (CENU)-resistant HT-29 cells, the eventual repletion of activity occurs with no concommitant alterations in steady-state MGMT mRNA levels. This suggestion of a potentially stable transcript prompted studies to define the relative contributions of MGMT mRNA stability and transcription to cellular MGMT expression. Northern analysis of MGMT mRNA in actinomycin D-treated HT-29, MR-1 and A2182 cells, ranging in relative MGMT expression from high to low respectively, demonstrates relatively long MGMT mRNA half-lives of > 10-12 h. Cell lines with low and moderate levels of MGMT mRNA appear to have longer mRNA half-lives than those with high levels. Run-on transcription in nuclei isolated from cells with low to moderate MGMT mRNA levels demonstrates undetectable basal MGMT transcription rates. Collectively these data suggest that a very low transcription rate, coupled with a stable mRNA molecule, might result in the translation of pre-existing mRNA molecules. This translation may be responsible for the gradual recovery of MGMT and CENU resistance over 24 h following MGMT depletion.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7554086     DOI: 10.1093/carcin/16.9.2255

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  8 in total

1.  Promoter hypermethylation of DNA repair gene MGMT in laryngeal squamous cell carcinoma.

Authors:  Song Zhang; Changkai Guo; Weijia Kong; Zheng Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

2.  Cytoplasmic sequestration of an O6-methylguanine-DNA methyltransferase enhancer binding protein in DNA repair-deficient human cells.

Authors:  F Y Chen; L C Harris; J S Remack; T P Brent
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

3.  Silencing of MGMT expression by promoter hypermethylation in the metaplasia-dysplasia-carcinoma sequence of Barrett's esophagus.

Authors:  Doerthe Kuester; Wa'el El-Rifai; DunFa Peng; Petra Ruemmele; Ivonne Kroeckel; Brigitte Peters; Christopher A Moskaluk; Manfred Stolte; Klaus Mönkemüller; Frank Meyer; Hans-Ulrich Schulz; Arndt Hartmann; Albert Roessner; Regine Schneider-Stock
Journal:  Cancer Lett       Date:  2008-11-21       Impact factor: 8.679

4.  Expression of O6-Methylguanine-DNA Methyltransferase Examined by Alkyl-Transfer Assays, Methylation-Specific PCR and Western Blots in Tumors and Matched Normal Tissue.

Authors:  Kimiko Ishiguro; Krishnamurthy Shyam; Philip G Penketh; Raymond P Baumann; Alan C Sartorelli; Thomas J Rutherford; Elena S Ratner
Journal:  J Cancer Ther       Date:  2013-06

5.  Regulation of O6-methylguanine-DNA methyltransferase by methionine in human tumour cells.

Authors:  D M Kokkinakis; M A von Wronski; T H Vuong; T P Brent; S C Schold
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 6.  O6-Methylguanine-DNA Methyltransferase (MGMT): Challenges and New Opportunities in Glioma Chemotherapy.

Authors:  Wei Yu; Lili Zhang; Qichun Wei; Anwen Shao
Journal:  Front Oncol       Date:  2020-01-17       Impact factor: 6.244

7.  MGMT assessment in pituitary adenomas: comparison of different immunohistochemistry fixation chemicals.

Authors:  Alexander S G Micko; Romana Höftberger; Adelheid Wöhrer; Matthias Millesi; Engelbert Knosp; Stefan Wolfsberger
Journal:  Pituitary       Date:  2018-06       Impact factor: 4.107

8.  Alkylation and Carbamylation Effects of Lomustine and Its Major Metabolites and MGMT Expression in Canine Cells.

Authors:  Thushara Chakkath; Sidonie Lavergne; Timothy M Fan; David Bunick; Levent Dirikolu
Journal:  Vet Sci       Date:  2015-04-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.